Fc-independent phagocytosis: implications for IVIG and other therapies in immune-mediated thrombocytopenia.
Li J, van der Wal DE, Zhu L, Vadasz B, Simpson EK, Li C, Webster ML, Zhu G, Lang S, Chen P, Zeng Q, Ni H.
Li J, et al. Among authors: zhu g, zhu l.
Cardiovasc Hematol Disord Drug Targets. 2013 Mar 1;13(1):50-8. doi: 10.2174/1871529x11313010006.
Cardiovasc Hematol Disord Drug Targets. 2013.
PMID: 23082940
Review.